NCT01872533

Brief Summary

The purpose of this study is to look at how a reduction in oxygen levels (hypoxia) influences insulin sensitivity and carbohydrate metabolism. It is expected that 10 nights of exposure to moderate hypoxia (\~ 15% O2, similar to conditions at an altitude of \~7500 feet) will improve glucose metabolism.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for early_phase_1

Timeline
Completed

Started Jul 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2011

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2012

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2013

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 3, 2013

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 7, 2013

Completed
Last Updated

December 2, 2015

Status Verified

December 1, 2015

Enrollment Period

1.2 years

First QC Date

June 3, 2013

Last Update Submit

December 1, 2015

Conditions

Keywords

obesityhypoxiainsulin sensitivityaltitude

Outcome Measures

Primary Outcomes (1)

  • Change in Insulin sensitivity

    Glucose disposal and oxidation were measured using a two-step hyperinsulinemic euglycemic clamp and indirect calorimetry.

    Change from baseline to 10 nights of hypoxia exposure

Secondary Outcomes (3)

  • Change in oxygen tension in adipose tissue

    Before and after 10 nights of hypoxia exposure

  • Glucose uptake in myotubes

    Before 10 nights of hypoxia exposure

  • Change in gene and protein expression

    Before and after 10 nights of hypoxia exposure

Study Arms (1)

Hypoxia Exposure

EXPERIMENTAL

There was only one study arm: All participants slept in moderate hypoxia (see description below).

Other: Hypoxia Exposure

Interventions

Participants spent 10 consecutive nights (approximately 100 hours of exposure) in a hypoxic tent at \~ 15% O2 (ca. 2400 m elevation).

Hypoxia Exposure

Eligibility Criteria

Age20 Years - 45 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Aged 20-45 years
  • Male
  • Obese category (BMI \> 30 kg/m2)
  • Healthy as assessed by a self-reported health questionnaire
  • Non-smokers
  • Weight stable over the past 3 months (\<2kg fluctuation)

You may not qualify if:

  • Female
  • Diabetes
  • Sleep apnea
  • Hypertension
  • History of altitude sickness
  • Individuals taking any chronic medications
  • Individuals taking any stimulants
  • Individuals taking beta-blockers
  • Individuals with chronic alcohol consumption (\>3 drinks per day) or drug abuse.
  • Individuals unable to abstain from caffeinated beverage or alcohol the days of study testing
  • Individuals with history disease or history of stroke

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pennington Biomedical Research Center

Baton Rouge, Louisiana, 70808, United States

Location

Related Publications (1)

  • Lecoultre V, Peterson CM, Covington JD, Ebenezer PJ, Frost EA, Schwarz JM, Ravussin E. Ten nights of moderate hypoxia improves insulin sensitivity in obese humans. Diabetes Care. 2013 Dec;36(12):e197-8. doi: 10.2337/dc13-1350. No abstract available.

MeSH Terms

Conditions

Insulin ResistanceObesityHypoxia

Condition Hierarchy (Ancestors)

HyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsSigns and Symptoms, Respiratory

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 3, 2013

First Posted

June 7, 2013

Study Start

July 1, 2011

Primary Completion

September 1, 2012

Study Completion

May 1, 2013

Last Updated

December 2, 2015

Record last verified: 2015-12

Locations